WebThe aim of this study was to define the toxicity, maximum feasible dose (MFD), and pharmacokinetics (PK) of Å6, a peptide derived from human urokinase plasminogen activator (uPA), in patients with advanced gynecologic cancers, and to explore anti-tumor activity and the effects of Å6 on biomarkers of the urokinase system. WebLike Google, Google Scholar allows searching of metadata terms, but unlike Google, it also indexes full text. Choose the default search or select “Advanced search” to search by title, author, journal, and date. For more advanced researchers, it is possible to specify phrases in quotation marks, enter Boolean queries, or search within fields.
Google Scholar
WebGoogle Scholar (GS) is a free academic search engine that can be thought of as the academic version of Google. Rather than searching all of the indexed information on the web, it searches repositories of publishers, universities or scholarly websites. This is generally a smaller subset of the pool that Google searches. WebJan 29, 2024 · SERPINE1 has the functions of anti-fibrinolysis, regulating cell adhesion and uPA/uPAR, and can indirectly regulate the growth of tumor cells . Anti-fibrinolysis enables SERPINE1 to maintain thrombin activity and activate receptor (PAR) through thrombin and protease of tumor cells. ... View at: Google Scholar “Updates on management of gastric ... pennsbury school district pupil services
Urokinase-type Plasminogen Activator (uPA) Binding to …
WebUrokinase-type plasminogen activator (uPA) augments inflammation and tissue remodeling during lung injury and repair. The uPA expression in small airway epithelium of chronic obstructive pulmonary disease (COPD) increases. Epithelial–mesenchymal transition (EMT) is important in the small airway fibrosis of COPD. This study shows the uPA regulation in … WebGoogle Scholar). A second problem was the length of the linker between the cysteine sulfur and the dansyl fluorophore ... FIGURE 8 Model of PAI-1 and PAI-1·uPA complex binding to LRP1. A, native PAI-1 binds to CR456 of cluster II of LRP1 through residues Lys-88 (CR4), Arg-76/Lys-80 (CR5), and Lys-69 ... WebApr 10, 2024 · UPA, a selective JAK1 inhibitor that also partly acts on JAK2, became available for clinical use in Japan in September 2024. ... , , [Web of Science ®], [Google Scholar] Reprints and Permissions. This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, … toast loyalty programs